Faculty of Biomedical Sciences and Engineering, and BioMediTech Institute, Tampere University of Technology, Tampere, Finland.
Faculty of Medicine and Life Sciences, and BioMediTech Institute, University of Tampere, Tampere, Finland.
Acta Biomater. 2017 May;54:138-149. doi: 10.1016/j.actbio.2017.02.035. Epub 2017 Feb 20.
Age-related macular degeneration (AMD) is the leading cause of vision loss in senior citizens in the developed world. The disease is characterised by the degeneration of a specific cell layer at the back of the eye - the retinal pigment epithelium (RPE), which is essential in retinal function. The most promising therapeutic option to restore the lost vision is considered to be RPE cell transplantation. This work focuses on the development of biodegradable biomaterials with similar properties to the native Bruch's membrane as carriers for RPE cells. In particular, the breath figure (BF) method was used to create semi-permeable microporous films, which were thereafter used as the substrate for the consecutive Langmuir-Schaefer (LS) deposition of highly organised layers of collagen type I and collagen type IV. The newly developed biomaterials were further characterised in terms of surface porosity, roughness, hydrophilicity, collagen distribution, diffusion properties and hydrolytic stability. Human embryonic stem cell-derived RPE cells (hESC-RPE) cultured on the biomaterials showed good adhesion, spreading and morphology, as well as the expression of specific protein markers. Cell function was additionally confirmed by the assessment of the phagocytic capacity of hESC-RPE. Throughout the study, microporous films consistently showed better results as cell culture materials for hESC-RPE than dip-coated controls. This work demonstrates the potential of the BF-LS combined technologies to create biomimetic prosthetic Bruch's membranes for hESC-RPE transplantation.
Age-related macular degeneration (AMD) is a leading cause of central blindness in developed countries, associated with the degeneration of the retinal pigment epithelium (RPE), a specific cell layer at the back of the eye. Transplantation of RPE cells derived from stem cells is considered the best option to treat these patients. In this work, we developed a cell carrier for human embryonic stem cell-derived RPE that resembled the upper layers of the membrane that naturally supports the RPE cells in the retina. The new combination of technologies employed in this study resulted in very promising materials as confirmed by our studies on cell proliferation, morphology and function.
年龄相关性黄斑变性(AMD)是发达国家老年人视力下降的主要原因。该疾病的特征是眼睛后部的一个特定细胞层 - 视网膜色素上皮(RPE)退化,这对视网膜功能至关重要。恢复失去视力最有希望的治疗选择被认为是 RPE 细胞移植。这项工作专注于开发具有类似于天然布鲁赫膜特性的可生物降解生物材料作为 RPE 细胞的载体。特别是,使用呼吸图(BF)方法来创建半渗透微孔膜,然后将其用作连续 Langmuir-Schäfer(LS)沉积高度组织的胶原蛋白 I 和胶原蛋白 IV 层的基底。新开发的生物材料进一步在表面孔隙率、粗糙度、亲水性、胶原蛋白分布、扩散特性和水解稳定性方面进行了表征。在生物材料上培养的人胚胎干细胞衍生的 RPE 细胞(hESC-RPE)表现出良好的粘附性、铺展性和形态,以及特定蛋白标志物的表达。通过评估 hESC-RPE 的吞噬能力,进一步证实了细胞功能。在整个研究过程中,微孔膜始终作为 hESC-RPE 的细胞培养材料表现出比浸涂对照更好的结果。这项工作证明了 BF-LS 联合技术在为 hESC-RPE 移植创建仿生假布鲁赫膜方面的潜力。
年龄相关性黄斑变性(AMD)是发达国家中心性失明的主要原因,与眼睛后部的视网膜色素上皮(RPE)退化有关,RPE 是一种特定的细胞层。从干细胞中移植 RPE 细胞被认为是治疗这些患者的最佳选择。在这项工作中,我们开发了一种用于人胚胎干细胞衍生的 RPE 的细胞载体,该载体类似于自然支持视网膜中 RPE 细胞的膜的上层。本研究中采用的新技术组合得到了非常有前途的材料,这一点在我们对细胞增殖、形态和功能的研究中得到了证实。